Millennium Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.93M Sell
40,000
-100
-0.2% -$4.66K ﹤0.01% 3906
2025
Q4
$1.94M Sell
40,100
-117,000
-74% -$5.8M ﹤0.01% 3978
2025
Q3
$7.42M Buy
157,100
+7,000
+5% +$338K ﹤0.01% 2706
2025
Q2
$7.25M Sell
150,100
-270,200
-64% -$13.8M ﹤0.01% 2598
2025
Q1
$23.3M Buy
420,300
+376,200
+853% +$20.4M 0.01% 1374
2024
Q4
$2.13M Sell
44,100
-108,700
-71% -$5.53M ﹤0.01% 3598
2024
Q3
$8.81M Sell
152,800
-63,400
-29% -$3.42M ﹤0.01% 2300
2024
Q2
$10.5M Buy
216,200
+188,700
+686% +$9.1M ﹤0.01% 2039
2024
Q1
$1.34M Buy
+27,500
New +$1.34M ﹤0.01% 4056
2023
Q3
Sell
-30,000
Closed -$1.62M 6526
2023
Q2
$1.62M Sell
30,000
-20,000
-40% -$1.08M ﹤0.01% 3663
2023
Q1
$2.72M Buy
+50,000
New +$2.43M ﹤0.01% 3140
2022
Q4
Sell
-25,000
Closed -$951K 7017
2022
Q3
$951K Buy
+25,000
New +$1.11M ﹤0.01% 4383
2022
Q1
Sell
-150,000
Closed -$7.51M 7444
2021
Q4
$7.51M Buy
+150,000
New +$7.42M ﹤0.01% 2466

Other funds holding SNY

Millennium Management's SNY Position: Q1 2026 in Review

Millennium Management increased its Sanofi (SNY) stake by 2,410% in Q1 2026, buying an estimated $154M and bringing the position to 3,440,654 shares worth $166M. The position accounts for 0.07% of the portfolio, ranked #259.

Millennium Management first reported a position in SNY in Q1 2014 and has held it in 34 quarters since. The position peaked at $176M in Q4 2022. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Millennium Management held 3,440,654 shares of Sanofi worth $166M as of Q1 2026.
  • Millennium Management bought 3,303,600 Sanofi shares in Q1 2026, an estimated $154M.
  • Sanofi made up 0.07% of Millennium Management's portfolio in Q1 2026, its #259 holding.
  • Millennium Management first reported a position in Sanofi in Q1 2014 and has held it in 34 quarters since.
  • Millennium Management's Sanofi position peaked at $176M in Q4 2022.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.